Stock Market Today, Oct. 20: Salesforce Agrees to Acquire Braze for $5.66 Billion: BRZE Stock Soars 52%

Salesforce agreed to acquire Braze for $47.50 per share in cash, valuing the deal at $5.66 billion; Braze closed at $45.57, up 51.70%, with volume 1,799% above its three-month average. The acquisition expands Salesforce's AI-focused customer engagement offerings, but Braze was not yet profitable and the purchase price is about 7 times trailing sales. The deal is expected to close in 2027, subject to completion risks; Braze traded within 4% of the offer price.

Analysis

The deal turns BRZE into a duration-and-completion-risk asset, not an operating-growth trade: at $45.57, the gross spread to $47.50 is about 4.2%, while the implied pre-announcement price is near $30. A delay into 2027 could therefore leave investors with modest carry against substantial break risk; the spread is not attractive absent confidence in closing and a view on downside protection. For CRM, the strategic upside is access to customer-engagement workflows and data that may improve cross-selling of its AI stack, but value creation depends on product integration and measurable retention or monetization—not the acquisition narrative. The cash commitment and roughly 7x trailing-sales purchase price raise the hurdle for returns, particularly before BRZE profitability. KVYO's sympathy rally creates both validation of the category and a risk that investors extrapolate takeover optionality without evidence of a bid. Over 1–3 months, monitor deal documentation, regulatory review, financing/termination provisions, and CRM commentary on integration and expected returns. Over 6–18 months, the thesis is falsified if CRM cannot show customer adoption or revenue contribution while acquisition-related costs rise; a material regulatory obstacle or termination would likely reprice BRZE toward standalone value.

Key Decisions for Investors

• Do not chase BRZE at the current spread. Treat a long as merger arbitrage only after checking the definitive agreement, termination protections, regulatory path, and expected close date; roughly 4.2% gross upside is poor compensation for the implied downside if the transaction breaks.
• For existing BRZE holders, consider trimming rather than treating the cash offer as assured value. Reassess on any regulatory delay, adverse deal-term disclosure, or evidence of a competing bid; the latter is upside optionality, not a base case.
• Keep CRM as a watch, not an event-driven short or long. Look for quantified integration milestones, customer attach/adoption, and acquisition-related expense or guidance changes; absent those, the strategic rationale alone does not establish accretion.
• Avoid extrapolating KVYO's sympathy move into a takeover thesis. Consider a fade only if the stock retains a deal-driven premium without company-specific estimate revisions or new strategic evidence; otherwise there is no clean trade signal.